Quick Takeaways
- Douglas E. Williams has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $368,957.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Douglas E. Williams and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | EVP & President, R&D | $368,957 | 07 Mar 2024 | ||
| CAMP | Camp4 Therapeutics Corp | Director | 17 Mar 2025 | |||
| CLYM | Climb Bio, Inc. | Director | 04 Jun 2025 | |||
| CDAKQ | Codiak BioSciences, Inc. | President & CEO, Director | 28 Mar 2023 | |||
| OVID | Ovid Therapeutics Inc. | Director | 17 May 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|